Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Phase 2
Terminated
- Conditions
- Constipation-predominant IBS (IBS-C)
- Interventions
- Dietary Supplement: NTX-1
- First Posted Date
- 2014-05-22
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Nutrabiotix, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT02144753
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
News
No news found